TY - JOUR T1 - Emerging roles of rare and low-frequency genetic variants in type 1 diabetes mellitus JF - Journal of Medical Genetics JO - J Med Genet SP - 289 LP - 296 DO - 10.1136/jmedgenet-2020-107350 VL - 58 IS - 5 AU - Haipeng Pang AU - Ying Xia AU - Shuoming Luo AU - Gan Huang AU - Xia Li AU - Zhiguo Xie AU - Zhiguang Zhou Y1 - 2021/05/01 UR - http://jmg.bmj.com/content/58/5/289.abstract N2 - Type 1 diabetes mellitus (T1DM) is defined as an autoimmune disorder and has enormous complexity and heterogeneity. Although its precise pathogenic mechanisms are obscure, this disease is widely acknowledged to be precipitated by environmental factors in individuals with genetic susceptibility. To date, the known susceptibility loci, which have mostly been identified by genome-wide association studies, can explain 80%–85% of the heritability of T1DM. Researchers believe that at least a part of its missing genetic component is caused by undetected rare and low-frequency variants. Most common variants have only small to modest effect sizes, which increases the difficulty of dissecting their functions and restricts their potential clinical application. Intriguingly, many studies have indicated that rare and low-frequency variants have larger effect sizes and play more significant roles in susceptibility to common diseases, including T1DM, than common variants do. Therefore, better recognition of rare and low-frequency variants is beneficial for revealing the genetic architecture of T1DM and for providing new and potent therapeutic targets for this disease. Here, we will discuss existing challenges as well as the great significance of this field and review current knowledge of the contributions of rare and low-frequency variants to T1DM. ER -